Suppr超能文献

避免在粪便微生物群移植后复发性感染中过早使用抗生素。

Avoiding Premature Antibiotic Use in Recurrent Infection After Fecal Microbiota Transplant.

作者信息

Burdette Rahim A, Whitt Caroline C, Behm Brian W, Warren Cirle A

机构信息

School of Medicine, University of Virginia, Charlottesville, VA.

Department of Physical Medicine and Rehabilitation, University of Virginia, Charlottesville, VA.

出版信息

ACG Case Rep J. 2025 Apr 3;12(4):e01660. doi: 10.14309/crj.0000000000001660. eCollection 2025 Apr.

Abstract

Recurrent infection (rCDI) remains a major clinical challenge, often requiring fecal microbiota transplantation (FMT) after conventional treatment fails. An 86-year-old woman with rCDI underwent FMT after failing multiple antibiotic therapies. Shortly after FMT, she experienced diarrhea and abdominal pain, alongside positive stool tests. Antibiotics were withheld because of clinical improvement, and she achieved complete resolution of symptoms without further treatment. This case demonstrates the potential benefit of withholding antibiotics in rCDI patients soon after FMT to allow sufficient time for donor microbiota engraftment and underscores the need for further research to optimize post-FMT management.

摘要

复发性艰难梭菌感染(rCDI)仍然是一个重大的临床挑战,常规治疗失败后通常需要进行粪便微生物群移植(FMT)。一名86岁的rCDI女性在多种抗生素治疗失败后接受了FMT。FMT后不久,她出现腹泻和腹痛,同时粪便检测呈阳性。由于临床症状改善,停用了抗生素,她未经进一步治疗症状完全缓解。该病例表明,在FMT后不久对rCDI患者停用抗生素,以便为供体微生物群植入留出足够时间,可能具有益处,并强调需要进一步研究以优化FMT后的管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7de/11968022/e52043b047c5/ac9-12-e01660-g001.jpg

相似文献

1
Avoiding Premature Antibiotic Use in Recurrent Infection After Fecal Microbiota Transplant.
ACG Case Rep J. 2025 Apr 3;12(4):e01660. doi: 10.14309/crj.0000000000001660. eCollection 2025 Apr.
2
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).
Cochrane Database Syst Rev. 2023 Apr 25;4(4):CD013871. doi: 10.1002/14651858.CD013871.pub2.
3
Factors associated with failure of fecal microbiota transplant for recurrent infection.
Therap Adv Gastroenterol. 2025 Apr 23;18:17562848251334517. doi: 10.1177/17562848251334517. eCollection 2025.
5
Microbiota restoration therapies for recurrent infection reach an important new milestone.
Therap Adv Gastroenterol. 2024 May 24;17:17562848241253089. doi: 10.1177/17562848241253089. eCollection 2024.

本文引用的文献

1
The burden of CDI in the United States: a multifactorial challenge.
BMC Infect Dis. 2023 Mar 7;23(1):132. doi: 10.1186/s12879-023-08096-0.
3
Predictors of Fecal Microbiota Transplant Failure in Clostridioides difficile Infection : An Updated Meta-analysis.
J Clin Gastroenterol. 2023 Apr 1;57(4):389-399. doi: 10.1097/MCG.0000000000001667.
4
ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections.
Am J Gastroenterol. 2021 Jun 1;116(6):1124-1147. doi: 10.14309/ajg.0000000000001278.
5
Faecalibacterium prausnitzii increases following fecal microbiota transplantation in recurrent Clostridioides difficile infection.
PLoS One. 2021 Apr 9;16(4):e0249861. doi: 10.1371/journal.pone.0249861. eCollection 2021.
8
Predictors of failure after fecal microbiota transplantation for recurrent Clostridioides difficile infection: a systematic review and meta-analysis.
Eur J Clin Microbiol Infect Dis. 2021 Jul;40(7):1383-1392. doi: 10.1007/s10096-021-04163-z. Epub 2021 Jan 26.
9
Faecal microbiota transplantation for recurrent infection: An updated systematic review and meta-analysis.
EClinicalMedicine. 2020 Nov 23;29-30:100642. doi: 10.1016/j.eclinm.2020.100642. eCollection 2020 Dec.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验